Discrimination of axillary metastatic from nonmetastatic lymph nodes with PROPELLER diffusion-weighted MR imaging in a metastatic breast cancer model and its correlation with cellularity

Journal of Magnetic Resonance Imaging

Volumn 36, Issue 3, 2012, Pages 624-631

  Junping, Wang ^a   Tongguo, Si ^a   Yunting, Zhang ^a   Chunshui, Yu ^a   Renju, Bai ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

animal model; axillary lymph node; cell density; diffusion weighted imaging

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; APPARENT DIFFUSION COEFFICIENT; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; BREAST METASTASIS; CELL SUSPENSION; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; ELECTRON SPIN RESONANCE; FEMALE; HISTOPATHOLOGY; IMAGE ANALYSIS; LYMPH NODE METASTASIS; MAMMARY GLAND; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RABBIT;

ANIMALS; AXILLA; BREAST NEOPLASMS; CARCINOMA; DIAGNOSIS, DIFFERENTIAL; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; LYMPH NODES; LYMPHATIC METASTASIS; RABBITS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; STATISTICS AS TOPIC;

EID: 84865335597     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.23695     Document Type: Article

References (32)

1. Wang L, Yao Q, Wang J, et al. MRI and hybrid PET/CT for monitoring tumor metastasis in a metastatic breast cancer model in rabbit. Nucl Med Commun 2008; 29: 137-143. (Pubitemid 350306771)
2. Orel SG, Schnall MD,. MR imaging of the breast for the detection, diagnosis, and staging of breast cancer. Radiology 2001; 220: 13-30. (Pubitemid 32577955)
3. Stets C, Brandt S, Wallis F, Buchmann J, Gilbert FJ, Heywang-Kobrunner SH,. Axillary lymph node metastases: a statistical analysis of various parameters in MRI with USPIO. J Magn Reson Imaging 2002; 16: 60-68. (Pubitemid 34700843)
4. Torabi M, Aquino SL, Harisinghani MG,. Current concepts in lymph node imaging. J Nucl Med 2004; 45: 1509-1518. (Pubitemid 47618505)
5. Park SO, Kim JK, Kim KA, et al. Relative apparent diffusion coefficient: determination of reference site and validation of benefit for detecting metastatic lymph nodes in uterine cervical cancer. J Magn Reson Imaging 2009; 29: 383-390.
6. Yasui O, Sato M, Kamada A,. Diffusion-weighted imaging in the detection of lymph node metastasis in colorectal cancer. Tohoku J Exp Med 2009; 218: 177-183.
7. Lin G, Ho KC, Wang JJ, et al. Detection of lymph node metastasis in cervical and uterine cancers by diffusion-weighted magnetic resonance imaging at 3T. J Magn Reson Imaging 2008; 28: 128-135. (Pubitemid 351956475)
8. Rechichi G, Galimberti S, Signorelli M, et al. Endometrial cancer: correlation of apparent diffusion coefficient with tumor grade, depth of myometrial invasion, and presence of lymph node metastases. AJR Am J Roentgenol 2011; 197: 256-262.
9. Roy C, Bierry G, Matau A, Bazille G, Pasquali R,. Value of diffusion-weighted imaging to detect small malignant pelvic lymph nodes at 3 T. Eur Radiol 2010; 20: 1803-1811.
10. Nakayama J, Miyasaka K, Omatsu T, et al. Metastases in mediastinal and hilar lymph nodes in patients with non-small cell lung cancer: quantitative assessment with diffusion-weighted magnetic resonance imaging and apparent diffusion coefficient. J Comput Assist Tomogr 2010; 34: 1-8.
11. Eiber M, Beer AJ, Holzapfel K, et al. Preliminary results for characterization of pelvic lymph nodes in patients with prostate cancer by diffusion-weighted MR-imaging. Invest Radiol 2010; 45: 15-23.
12. Chen YB, Liao J, Xie R, Chen GL, Chen G,. Discrimination of metastatic from hyperplastic pelvic lymph nodes in patients with cervical cancer by diffusion-weighted magnetic resonance imaging. Abdom Imaging 2011; 36: 102-109.
13. Holzapfel K, Duetsch S, Fauser C, Eiber M, Rummeny EJ, Gaa J,. Value of diffusion-weighted MR imaging in the differentiation between benign and malignant cervical lymph nodes. Eur J Radiol 2009; 72: 381-387.
14. Yamashita Y, Kumabe T, Higano S, Watanabe M, Tominaga T,. Minimum apparent diffusion coefficient is significantly correlated with cellularity in medulloblastomas. Neurol Res 2009; 31: 940-946.
15. Schnapauff D, Zeile M, Niederhagen MB, et al. Diffusion-weighted echo-planar magnetic resonance imaging for the assessment of tumor cellularity in patients with soft-tissue sarcomas. J Magn Reson Imaging 2009; 29: 1355-1359.
16. Zelhof B, Pickles M, Liney G, et al. Correlation of diffusion-weighted magnetic resonance data with cellularity in prostate cancer. BJU Int 2009; 103: 883-888.
17. Yuan YH, Xiao EH, Xiang J, et al. MR diffusion-weighted imaging of rabbit liver VX-2 tumor. World J Gastroenterol 2005; 11: 3070-3074. (Pubitemid 40790665)
18. Geschwind JF, Artemov D, Abraham S, et al. Chemoembolization of liver tumor in a rabbit model: assessment of tumor cell death with diffusion-weighted MR imaging and histologic analysis. J Vasc Interv Radiol 2000; 11: 1245-1255.
19. Shetty MK, Carpenter WS,. Sonographic evaluation of isolated abnormal axillary lymph nodes identified on mammograms. J Ultrasound Med 2004; 23: 63-71. (Pubitemid 38113827)
20. Krishnamurthy S, Sneige N, Bedi DG, et al. Role of ultrasound-guided fine-needle aspiration of indeterminate and suspicious axillary lymph nodes in the initial staging of breast carcinoma. Cancer 2002; 95: 982-988. (Pubitemid 34925346)
21. Obwegeser R, Lorenz K, Hohlagschwandtner M, Czerwenka K, Schneider B, Kubista E,. Axillary lymph nodes in breast cancer: is size related to metastatic involvement? World J Surg 2000; 24: 546-550. (Pubitemid 30210843)
22. Yoshimura G, Sakurai T, Oura S, et al. Evaluation of axillary lymph node status in breast cancer with MRI. Breast Cancer 1999; 6: 249-258.
23. Woodhams R, Ramadan S, Stanwell P, et al. Diffusion-weighted Imaging of the breast: principles and clinical applications. Radiographics 2011; 31: 1059-1084.
24. Usuda K, Zhao XT, Sagawa M, et al. Diffusion-weighted imaging is superior to positron emission tomography in the detection and nodal assessment of lung cancers. Ann Thorac Surg 2011; 91: 1689-1695.
25. Wang FN, Huang TY, Lin FH, et al. PROPELLER EPI: an MRI technique suitable for diffusion tensor imaging at high field strength with reduced geometric distortions. Magn Reson Med 2005; 54: 1232-1240.
26. Pipe JG,. Motion correction with PROPELLER MRI: application to head motion and free-breathing cardiac imaging. Magn Reson Med 1999; 42: 963-969. (Pubitemid 29521487)
27. Deng J, Virmani S, Young J, et al. Diffusion-weighted PROPELLER MRI for quantitative assessment of liver tumor necrotic fraction and viable tumor volume in VX2 rabbits. J Magn Reson Imaging 2008; 27: 1069-1076. (Pubitemid 351614618)
28. Sumi M, Sakihama N, Sumi T, et al. Discrimination of metastatic cervical lymph nodes with diffusion-weighted MR imaging in patients with head and neck cancer. AJNR Am J Neuroradiol 2003; 24: 1627-1634. (Pubitemid 37151732)
29. Vandecaveye V, De Keyzer F, Vander Poorten V, et al. Head and neck squamous cell carcinoma: value of diffusion-weighted MR imaging for nodal staging. Radiology 2009; 251: 134-146.
30. Mizukami Y, Ueda S, Mizumoto A, et al. Diffusion-weighted magnetic resonance imaging for detecting lymph node metastasis of rectal cancer. World J Surg 2011; 35: 895-899.
31. Humphries PD, Sebire NJ, Siegel MJ, Olsen A.E,. Tumors in pediatric patients at diffusion-weighted MR imaging: apparent diffusion coefficient and tumor cellularity. Radiology 2007; 245: 848-854. (Pubitemid 350127356)
32. Sadeghi N, D'Haene N, Decaestecker C, et al. Apparent diffusion coefficient and cerebral blood volume in brain gliomas: relation to tumor cell density and tumor microvessel density based on stereotactic biopsies. AJNR Am J Neuroradiol 2008; 29: 476-482. (Pubitemid 351424060)